Washington State University
Follicle-stimulating hormone provokes genetic changes in the murine testis
Published in Law and Health Weekly, January 8th, 2005
"Even though follicle stimulating hormone (FSH) is not required for qualitatively normal spermatogenesis, it plays an important role in the spermatogenic capacity of the testis. Although the actions of FSH are well documented, most of these studies were done in vitro, and the molecular targets of FSH in vivo remain largely unverified," investigators in the United States report.
"To understand the complete mechanism of FSH actions in spermatogenesis, it is important to identify the genes that are involved in its signaling, and know how these genes are affected by FSH," said...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP
New York attorney general enlists seniors to monitor drug prices - Accreditations
Humana's Louisiana operations awarded 3-year Excellent Accreditation by NCQA - Active Biotech
U.S. patent granted for biotech company's cancer project - Celgene Corporation
Patents licensed to isotretinoin manufacturers for safe distribution - Ciphergen Biosystems, Inc.
Proteomic analysis of circulating platelets can help with early cancer diagnosis - Healthcare Coverage
Humana to introduce New Medicare Advantage PPO plan to Kansas City area seniors - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
